Do we really need long-term hepatitis B hyperimmune globulin? What are the alternatives?
Article first published online: 29 SEP 2008
Copyright © 2008 American Association for the Study of Liver Diseases
Supplement: Liver Transplant for Viral Hepatitis and Fulminant Hepatic Failure
Volume 14, Issue Supplement S2, pages S23–S26, October 2008
How to Cite
Lake, J. R. (2008), Do we really need long-term hepatitis B hyperimmune globulin? What are the alternatives?. Liver Transpl, 14: S23–S26. doi: 10.1002/lt.21637
- Issue published online: 29 SEP 2008
- Article first published online: 29 SEP 2008
- Manuscript Received: 22 AUG 2008
- Manuscript Accepted: 22 AUG 2008
- 1The outcomes of liver transplantation for patients with hepatitis are the best for any diagnosis.
- 2Prevention of HBV re-infection is the key to excellent outcomes after liver transplantation.
- 3The use of hepatitis B immunoglobulin to prevent HBV re-infection is effective, but costly and with side effects.
- 4Effective prophylaxis against HBV re-infection can now be accomplished with combination nucleoside/nucleotide anti-virals.
Liver Transpl 14:S23–S26, 2008. © 2008 AASLD.